Fifty years have passed since
Introduction
The first 50 years of THA in the modern era has passed. Thus, it is reasonable to examine retrospectively this fivedecade experience and inquire into what lessons can be derived from such a review, lessons that lie behind the single dominant observation that in its present form, THA represents one of the most successful major operations ever devised for the treatment of end-stage human disease.
Many ideas concepts, developments, and inventions have contributed to the current state of the art, but a simple listing of each of these landmarks would be less valuable than a broader, generic assessment of the major contributions. Such a broad overview, moreover, could be helpful for accessing key ingredients in both future development of THA and for the development of other parallel innovative endeavors.
The five broad important observations, some obvious and some not, that can be drawn from this 50-year experience can be highlighted as follows: (1) skunk works; (2) Pasteur's motto; (3) the totally unexpected; (4) research works; and (5) the role of alternatives.
The Five Observations
A brief description of these five lessons and their roles in 50 years of progress follows.
The definition of ''skunk works'' by the McKenzie Company, the industrial consultants, may be paraphrased to be a very nontraditional innovative effort, which is The author has received funding from the William H. Harris, MD, Foundation.
offline, off-budget, remarkably innovative, driven by creative zealots, uninhibited by failure, and relentless.
The development of THA, particularly in the guise of Sir John Charnley, is a classic ''skunk works.'' In the Teflon experience, the short-term clinical results were nearly as stunning as the incredibly high failure rates [4] . Recall that at one time, the single most common operation Charnley did was resection arthroplasty on a failed Teflon THA. Yet, the contemporary overall magnificent results of THA speak to the unbelievable drive, intelligence, dedication, and persistence of a few, primarily Sir John Charnley, but also Boutin and McKee. One of the greatest scientists of all time, Louis Pasteur, had a motto that might loosely be translated as ''Chance favors the prepared mind.'' This is serendipity. The serendipity examples in the development of THA have unique clarity. In brief, Charnley's question dealing with a plastic grouting material for fixation of the femoral component was addressed to Dennis Smith, a chemist working for a PhD degree at Turner Dental Hospital in Manchester, UK [4] . Charnley asked ''what plastics could be used to hold a hip prosthesis in the femur?'' Smith's answer, ''methylmethacrylate,'' was based on the use of methylmethacrylate in the mouth, which is far from being equivalent to its use in the internal milieu of the body. However, his answer worked. It is still working 50 years later. That is serendipity.
As Pasteur's experience reflects, had Charnley's mind not been prepared to ask the question and then act on the answer from Dennis Smith, although the answer was unsupported by fact, THA would have been set back decades.
Similarly, the story of Charnley's introduction to ultrahigh-molecular-weight polyethylene (UHMWPE), again central to the entire 50-year effort and the savior of his Teflon experience, is pure serendipity. An UHMWPE salesman made the unusual deduction that because his polyethylene was used in making gears, it might be acceptable to use in the body for THAs. He visited Charnley's laboratory technician. Charnley dismissed the material. Charnley's laboratory technician tested this material at night without telling his boss and history was made [4] .
The third dominating lesson is the importance of the ''totally unexpected.'' The admonition to be learned is ''Always expect the unexpected.'' With the introduction of UHMWPE into THA in November 1962, the world of THA changed radically. The early wear results were so good and the durability so much improved over Teflon that the intensity of most subsequent research focused narrowly on an entirely different set of problems, namely sepsis, fixation, and fatal pulmonary emboli.
The fatal pulmonary embolism rates of one in every 50 patients [5, 6] , infection rates of 9.5% to 11% [3, 25] , and the increasing failure of cement fixation drove unprecedented scientific programs that have now very successfully protected most patients against all three of these complications.
However, unknowingly, although the focus was so intently on these issues, the totally unexpected, namely periprosthetic osteolysis [9, 23, 24] , was totally unrecognized and severely undermined the long-term success of THA. Specifically because it was very late to develop, insidious, clinically silent, and widespread, it was enigmatic. What was causing this late massive bone loss that resembled metastatic malignancy more closely than any other known pathology of that day?
Because the remarkably slower wear of the UHMWPE was very reassuring, no one envisioned that a unique type of wear was occurring: the generation of submicron particles through a previously unknown wear mechanism [11] and, even more alarming, the destructive macrophageinduced response to these particles produced periprosthetic osteolysis [10] .
The ''unexpected'' lay in the fact that the very process of creating a successful artificial total joint had inadvertently produced, for the first time in human history, an in vivo wear machine that spewed out a zillion tiny particles in vivo over decades of time [12] . Thus, a new, unique, manmade, ''never seen before'' disease was created without realizing it: the totally unexpected.
The fourth lesson lies in the unraveling of this bizarre process of periprosthetic osteolysis. The solution of this enigma speaks to the strength of contemporary medical research in the Western world. Periprosthetic osteolysis is now extensively understood in terms of its mechanism of action, the material science involved, and the complex molecular biology that underlies it [10, 11] . From a myriad of multifaceted investigations have come not only an understanding of the nature of the problem, but also several very promising but widely disparate modes of reduction, prevention, and/or treatment of the problem [13, 16, 19, 21, 22] . At a different time in human history, such could not have occurred. At a different place in the world during this same time, other than Western civilization with its emphasis on science and its resources, solutions would be unlikely. Research works.
Finally, the fifth major lesson from these first 50 years is the role of alternatives. Galante and Rostoker and coworkers received a Kappa Delta Award in 1970 on a strange new idea [7] , namely bony ingrowth, a biologic form of component fixation. Thirty-eight years later, this is the dominant form of fixation for THA throughout North America and a strong contender worldwide. Just as Charnley and McKee thought ''outside the box'' in their quest for a totally artificial hip, Galante and Rostoker overturned the ''grout'' concept of skeletal fixation and thought biologically.
Similarly, the alternatives of ceramic [8] and of metalon-metal [14, 20] articulations have proven successful. Moreover, subsequent to the new understanding of the mechanisms of lysis from UHMWPE in humans, the innovations of crosslinking plus melting [14, 15, 20] or crosslinking with added antioxidants [17, 18] have reestablished metal-on-crosslinked polyethylene as a leading choice for articulation [1] . These alternate bearings have also decreased loosening of the components, increased durability of the operations, and increased the opportunity to operate successfully on younger patients. Moreover, the alternative bearings have substantially improved the issues of range of motion, dislocation, and treatment of dislocation [2] .
Discussion
A singular limitation of the selection of these five ''lessons'' from the experience of the first 50 years of THA is that it represents the analysis of a single observer. One of the strengths may be that the single observer has followed and been a participant in the experience throughout 42 of those years. Perhaps strength lies in looking broadly at the types of processes that dominated the progress over that duration rather than listing multiple individual milestones.
In North America, the femoral components implanted are mostly cementless. The acetabular components used are largely cementless. Alternate bearings dominate with a growing movement toward heads 32 mm or larger. Does this mean we have abandoned Charnley, as a superficial reading would suggest? Far from it. His innovation and his unswerving pursuit of his dream underlie everything that has been done in the past 50 years. Indeed, during those five decades, the process of THA has been built better, much better. In the future, more and better things will come, but in that process, this experience emphasizes that it is crucial to keep clearly in mind these five key features, namely ''skunk works,'' Pasteur's motto, the totally unexpected, the power of contemporary medical research, and the role of alternatives as well, obviously, as-yet additional unanticipated lessons.
